Our business strategy includes acquiring licenses held by others who are seeking to monetize the value of their licenses.

We intend to acquire licenses to partner-funded commercial or pre-commercial assets from companies, universities, or individuals who hold rights to milestones and/or royalties from therapeutic products. Ultimately, we intend to build XOMA into the preferred acquirer of these milestone and/or royalty assets, by offering companies a win/win alternative for monetizing licenses with potential future value.

The Company intends to build upon its current portfolio by employing multiple strategies to acquire additional license interests in partner-funded programs.

Please contact for more information.